// App-Quantinova.ai

: Tumor microenvironment evaluation to predict anti–PD-1 response of advanced gastric cancer: Results from a multicenter prospective clinical trial.

Researchers

Presenter

  • Wangjun Liao

Principal Investigators

  • Dongqiang Zeng

  • Huiyan Luo

  • Jian Xiao

  • Feng Ye

  • Hailin Xiong

  • Xia Yuan

  • Yisheng Huang

  • Yongqiang Li

  • Na Huang

  • Jianhua Wu

  • Shaowei Li

  • Siting Zheng

  • Jiani Wu

  • Li Sun

  • Xiaoxiang Rong

  • Chunlin Wang

  • Jian Guo

  • Qiong Deng

Medical Centers

  • Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China

  • Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Sun Yat-Sen University Cancer Center, Guangdzhou, Guangdong, China

  • Department of Medical Oncology, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China

  • Department of Hematology, Shanghai Sixth People's Hospital, Shanghai, China

  • Department of Medical Oncology. Quanzhou First Hospital, Quanzhou, China

  • Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China

  • Department of Medical Oncology, Huizhou First Hospital, Huizhou, Huizhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Mismatch repair deficiency

  • Gastric Cancer

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 206

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • NCT04850716

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved